Journal profile

Cancer biomarkers : section A of Disease markers

Publisher: SAGE Publications
ISSN1574-0153 | 1875-8592 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.18
Citation rate 2.17 372 total citations
h5-index 27 h5 depth signal
Cited share 67.9% 125 of 184
Total citations 372 Citation footprint
Metric signal 2.51 External metric anchor
Self-citation 0.0% 0 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 756
United States 92
Iran 42
Egypt 36
India 29

Citing Fields of Research

Noncoding RNA 459
Oncology 430
Cancer & Development 393
Lung Cancer 172
Liver & Colon Cancer 151

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 2,036 Articles tracked across the journal lifetime
Indexed publication set 184 125 cited publications
Last 12 months 31 3.9 publications/month
Open access share 100.0% 31 OA publications in the last year
Leading citing country China 756 citing publications
Leading citing field Noncoding RNA 459 citing publications
Latest tracked publication 23 June 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, 2005-
PubMed
v1n1, 2005-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Oncology Lung Cancer Immunology Cancer & Development Noncoding RNA Breast Cancer

Broad Categories

Biochemistry Neoplasms Noncoding RNA Cancer, Autophagy & Apoptosis Lung Cancer Urology Immunology Cancer & Development

MeSH Descriptors

Biomarkers, Tumor. Neoplasms

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Roya Karami, Elaheh Najafi, Anahita Babaei et al.
Background: miRNAs are of interest due to have been involved in cancers such as colorectal cancer (CRC). Objective: To explore the expression levels of miRNA-34a and miRNA-135b and whether they can be potential biomarker for early diagno...
08
Yu Yan, Zhenguo Liu, Dawei Zhou et al.
Background: The heterogeneity of hepatocellular carcinoma (HCC) complicates diagnosis and treatment, and previous prognostic models have failed to yield satisfactory results. Given that the metabolic reprogramming of cholesterol plays a ...
09
Tao Lyu, Minghui Li, Huimin Li et al.
Background: Accurate staging and treatment response assessment remain challenging in cervical cancer management. This study investigated the diagnostic and prognostic value of integrating ultrasonographic parameters with serum and tissue...

Bibliographical & Catalog Notes

Also issued online.